Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yun Chen, Chaojin Hong, Jing Qu, Junjun Chen & Zhiquan Qin. (2022) Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis. Bioengineered 13:5, pages 12834-12846.
Read now
Read now
Xi Hong, Liang Mao, Luwei Xu, Qiang Hu & Ruipeng Jia. (2022) Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes. Bioengineered 13:1, pages 995-1012.
Read now
Read now
Articles from other publishers (6)
Deisy Morselli Gysi & Albert-László Barabási. (2023) Noncoding RNAs improve the predictive power of network medicine. Proceedings of the National Academy of Sciences 120:45.
Crossref
Crossref
Zhuowei Wang, Yinxin Wu, Zhuoyin Du, Fangshun Tan, Yunxi Zhou, Zhicheng Zhang & Chengfu Yuan. (2023) The Dual Functions of Non-Coding RNA CRNDE in Different Tumors. Mini-Reviews in Medicinal Chemistry 23:6, pages 719-733.
Crossref
Crossref
Soudeh Ghafouri-Fard, Arash Safarzadeh, Bashdar Mahmud Hussen, Mohammad Taheri & Majid Mokhtari. (2023) Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms. Pathology - Research and Practice 244, pages 154387.
Crossref
Crossref
Chuigong Yu, Yu Fan, Yu Zhang, Lupeng Liu & Gang Guo. (2022) LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway. Cancer Cell International 22:1.
Crossref
Crossref
Xiaoqiang Feng, Yuehua Chen, Xuanyu Liu, Zhihui Zhong & Yanjun Liu. (2022) Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas. Journal of Oncology 2022, pages 1-19.
Crossref
Crossref
Nan Wang, Rou Li, Huizhen Jia, Hui Xie, Chi Liu, Shan Jiang, Ke Zhang, Ping Lin & Xiaoguang Yu. (2022) Apaf‐1 interacting protein, a new target of microRNA‐146a‐3p, promotes prostate cancer cell development via the ERK1/2 pathway. Cell Biology International 46:7, pages 1156-1168.
Crossref
Crossref